Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	TREATMENT
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.2277	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.2277	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.2403	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.3224	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.4896	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.6023	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.7267	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.7774	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	0.9839	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.0161	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.0468	Peak area	Plasma	Angiotensin II
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.1472	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.1788	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.3878	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.5831	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	1.6506	Peak area	Plasma	Saline
Reversed phase NEGATIVE ION MODE	4-hydroxybenzoate	2.3206	Peak area	Plasma	Angiotensin II